Dermata Therapeutics, Inc.
DRMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,287 | -$7,795 | -$9,611 | -$7,902 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $658 | $522 | $930 | $1,905 |
| Change in WC | $467 | $864 | -$154 | $290 |
| Other Non-Cash | $0 | $0 | $0 | $14 |
| Operating Cash Flow | -$11,163 | -$6,409 | -$8,834 | -$5,693 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1,006 |
| Stock Issued | $6,886 | $7,606 | $4,276 | $15,386 |
| Stock Repurch. | -$1 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | -$430 |
| Financing Cash Flow | $6,886 | $7,606 | $4,277 | $15,962 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,277 | $1,197 | -$4,558 | $10,268 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,438 | $6,241 | $10,799 | $530 |
| End Cash | $3,162 | $7,438 | $6,241 | $10,799 |
| Free Cash Flow | -$11,163 | -$6,409 | -$8,834 | -$5,693 |